1. |
- Duker, Elisabeth, et al.
(författare)
-
The use of CMC as a dry strength agent - the interplay between CMC attachment and drying.
- 2008
-
Ingår i: Nordic Pulp & Paper Research Journal. - : Walter de Gruyter GmbH. - 0283-2631 .- 2000-0669. ; 23:1, s. 65-71
-
Tidskriftsartikel (refereegranskat)abstract
- This paper deals with the ability to use high molecular weight CMC as a dry strength agent in paper and how the drying of the pulp, either before or after the CMC attachment, affects the mechanical properties of the paper. The effect of the counter-ion form used during drying and reslushing was also investigated. In the case of the calcium and hydrogen counter-ion forms, drying after CMC attachment had no impact on the attached amount. The sodium form did, however, result in some detachment of CMC. When the pulp was dried prior to CMC treatment, the counter-ion form had no effect on the attached amount. It was also shown that drying of a CMC-treated pulp reduced the positive effect of CMC on the mechanical properties. Nevertheless, the mechanical properties were still better than those of paper made from the never-dried reference pulp. The relative effect of CMC on the mechanical properties was independent of the drying strategy used and the counter-ion form did not affect the mechanical properties. However, surface carboxymethylation prior to drying resulted in sheets with better final mechanical properties than sheets made from pulp that had first been dried and then surface carboxymethylated.
|
|
2. |
- Bremer, Hanna, et al.
(författare)
-
ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease
- 2018
-
Ingår i: Scientific Reports. - : NATURE PUBLISHING GROUP. - 2045-2322. ; 8
-
Tidskriftsartikel (refereegranskat)abstract
- Dogs can spontaneously develop complex systemic autoimmune disorders, with similarities to human autoimmune disease. Autoantibodies directed at self-antigens are a key feature of these autoimmune diseases. Here we report the identification of interleukin enhancer-binding factors 2 and 3 (ILF2 and ILF3) as autoantigens in canine immune-mediated rheumatic disease. The ILF2 autoantibodies were discovered in a small, selected canine cohort through the use of human protein arrays; a method not previously described in dogs. Subsequently, ILF3 autoantibodies were also identified in the same cohort. The results were validated with an independent method in a larger cohort of dogs. ILF2 and ILF3 autoantibodies were found exclusively, and at a high frequency, in dogs that showed a speckled pattern of antinuclear antibodies on immunofluorescence. ILF2 and ILF3 autoantibodies were also found at low frequency in human patients with SLE and Sjogren's syndrome. These autoantibodies have the potential to be used as diagnostic biomarkers for canine, and possibly also human, autoimmune disease.
|
|
3. |
|
|